GJA1 isoforms protect against metabolic stress
US11433116B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2017 |
| Grant date | Sep 6, 2022 |
| Priority date | — |
| Expiry date | May 5, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes methods of treating, preventing, reducing the likelihood of having, reducing the severity of and/or slowing the progression of a medical condition related to ischemia/reperfusion in a subject using GJA1-20k as a therapeutic agent. The invention further provides a method of protecting a cell from metabolic stress, using GJA1-20k. The invention also provides for a composition and/or gene expression vector comprising GJA1-20k.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.